OBIO SCHEDULE 13D/A: SEC filing

RTW Investments LP and Roderick Wong

Filed with the SEC on · accession 0001493215-26-000170

OBIO filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 12, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

RTW Investments LP and Roderick Wong filed an amended Schedule 13D reporting beneficial ownership of 13,142,394 shares (16.2%) of Orchestra BioMed Holdings, after purchasing 1,200,000 shares at $5.00 per share from underwriters of the issuer's public offering on November 9, 2026.

Key details

Shares purchased from underwriters of public offering$1.2M
Purchase price per share$5
Total purchase value (1,200,000 shares x $5.00)$6.0M
Aggregate shares beneficially owned after transaction$13.1M
Reporting person / beneficial owner / investment advisor to rtw fundsRTW Investments, LP
Issuer / subject companyOrchestra BioMed Holdings, Inc.
Managing partner and chief investment officer of rtw investments, lpRoderick Wong, M.D.

✦ Ask GOAX AI about this filing — what it means for OBIO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for OBIO?

Click here

Frequently asked questions

What did OBIO file with the SEC on Nov 12, 2026?

OBIO filed a SCHEDULE 13D/A (SEC filing). RTW Investments LP and Roderick Wong filed an amended Schedule 13D reporting beneficial ownership of 13,142,394 shares (16.2%) of Orchestra BioMed Holdings, after purchasing 1,200,000 shares at $5.00 per share from underwriters of the issuer's public offering on November 9, 2026.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

Other OBIO SEC filings

Get alerts when OBIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days